Business / Finance

RSS

HUYA Bioscience International announces strategic partnership with CZCBD

HUYA Bioscience International, a leader in accelerating the global development of China's pharmaceutical innovations, today announced a strategic partnership with the Changzhou Center for Biotech Development (CZCBD).

18 Aug 2014

Prime Healthcare completes acquisition of St. Mary's Hospital in Passaic, New Jersey

Prime Healthcare announced today that it has completed its acquisition of St. Mary's Hospital in Passaic, New Jersey.

16 Aug 2014

Catasys total revenues up 192% in second quarter 2014

Catasys, Inc., provider of proprietary health management services to health insurers and employers, today announced its financial results for the second quarter ended June 30, 2014.

15 Aug 2014

ULURU reports revenues of $209,000 for second quarter 2014

ULURU Inc. today announced its financial results for the second quarter ended June 30, 2014 and provided a review of its operating activities.

15 Aug 2014

China Pharma Holdings' Q2 2014 revenue decreases by 24% to $6.1 million

China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced its financial results for the three months ended June 30, 2014.

15 Aug 2014

Dyadic's net product related revenue for Q2 2014 increases 28% to $4.9 million

Dyadic International, Inc., a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, today announced financial results for the second quarter ended June 30, 2014.

14 Aug 2014

RBC Life Sciences net sales increase 18% to $7.9 million in second quarter 2014

RBC Life Sciences, Inc., a provider of proprietary nutritional supplements, and wound care and pain management products, today reported consolidated net sales of $7.9 million for the quarter ended June 30, 2014, an 18% increase over net sales of $6.7 million in the second quarter of 2013.

14 Aug 2014

Novogen declares shareholder meeting results

Australia-US biotechnology company, Novogen Ltd., an oncology and degenerative diseases drug development company, today announced the results of its General Meeting of Shareholders, which was held on August 12 in Sydney, Australia.

13 Aug 2014

Leica Biosystems, ACD co-market RNAscope LS ISH assays and BOND RX instrument

Leica Biosystems and Advanced Cell Diagnostics, Inc. (ACD) have announced the co-marketing of ACD's RNAscope® LS ISH assays with Leica Biosystems' BOND RX research staining platform.

From Advanced Cell Diagnostics 13 Aug 2014

HCN to acquire HealthLease REIT and 17 of Mainstreet's Next Generation properties

The nation's largest post-acute health care developer and one of the world's largest health care real estate companies have agreed to join forces to lead the evolution of post-acute care, an emerging solution in the changing health care landscape.

13 Aug 2014

BDMS revenue increases 2.7% to $16.9M in second quarter 2014

Birner Dental Management Services, Inc.,operators of PERFECT TEETH® dental practices, announced results for the quarter and six months ended June 30, 2014.

13 Aug 2014

Neovasc revenues increase 58% to $4,404,515 in Q2 2014

Neovasc Inc. ("Neovasc" or the "Company") today announced financial results for the three months ended March 31, 2014. All results are reported in Canadian dollars unless otherwise stated.

13 Aug 2014

Tarsa obtains $10 million senior credit facility to support NDA submission for Ostora tablet

Tarsa Therapeutics, Inc. today announced that it has secured a $10 million senior credit facility from Oxford Finance LLC and Square 1 Bank. The company intends to use the proceeds to support its plans to file a New Drug Application (NDA) with the U.S. Food and Drug Administration for its Ostora tablet for the treatment of postmenopausal osteoporosis, currently targeted for early 2015.

13 Aug 2014

Tackling rising healthcare costs: an interview with Professor Graeme Currie, Warwick Business School

I think the main reason involves the impact of an aging population, some of whom age healthily, but many of whom, unhealthily, particularly those from poorer sectors of society.

12 Aug 2014

ChromaDex reports 42% increase in Q2 2014 net sales

ChromaDex Corp., an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today the financial results for the quarter ended June 28, 2014.

12 Aug 2014

GenVec reports net loss of $1.7 million for second quarter 2014

GenVec, Inc. today reported financial results for the three-month and six-month periods ended June 30, 2014. For the three-month period ended June 30, 2014, the company reported a net loss of $1.7 million or $0.10 per share on revenues of $0.1 million as compared to a net loss of $3.1 million or $0.24 per share on revenues of $0.7 million in the same period in the prior year.

12 Aug 2014

Ability Dynamics secures distribution in Canada for RUSH HiPro and RUSH LoPro prosthetic feet

Ability Dynamics, LLC announced today it has secured an exclusive Canadian distribution relationship for its flagship products the RUSH HiPro and the RUSH LoPro prosthetic feet.

12 Aug 2014

Oncothyreon reports decreased net operating loss in Q2 2014

Oncothyreon Inc. today reported financial results for the second quarter ended June 30, 2014. Loss from operations decreased to $7.8 million for the three months ended June 30, 2014 compared with $18.0 million for the comparable period in 2013, and decreased to $15.0 million for the six months ended June 30, 2014 compared with $26.0 million for the comparable period in 2013.

12 Aug 2014

Skilled Healthcare Group Q2 2014 revenue decreases 1.5% to $207 million

Skilled Healthcare Group, Inc. today announced its consolidated financial operating results for the three and six month period ended June 30, 2014.

12 Aug 2014

Mindray net revenues increase 8.9% to $334.5 million in Q2 2014

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2014.

From Mindray 12 Aug 2014